SC
NKTR icon

Steven Cohen’s Nektar Therapeutics NKTR Stock Holding History

Steven Cohen’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,364
Closed -$962K – 4411
2026
Q1 		$962K Sell
13,364
-420,055
-97% -$23.9M ﹤0.01% 2781
2025
Q4 		$18.3M Buy
433,419
+309,761
+250% +$17.3M 0.02% 946
2025
Q3 		$7.04M Buy
+123,658
New +$4.09M 0.01% 938
2023
Q4 		– Sell
-101,372
Closed -$906K – 2594
2023
Q3 		$906K Buy
101,372
+99,848
+6,552% +$961K ﹤0.01% 1358
2023
Q2 		$13.1K Buy
+1,524
New +$16.3K ﹤0.01% 1866
2022
Q2 		– Sell
-29,587
Closed -$2.39M – 1556
2022
Q1 		$2.39M Sell
29,587
-1,233
-4% -$182K 0.01% 849
2021
Q4 		$6.25M Sell
30,820
-4,320
-12% -$937K 0.02% 622
2021
Q3 		$9.47M Buy
+35,140
New +$8.45M 0.04% 505
2020
Q2 		– Sell
-1,045
Closed -$280K – 951
2020
Q1 		$280K Buy
+1,045
New +$323K ﹤0.01% 700
2018
Q2 		– Sell
-1,473
Closed -$2.35M – 1119
2018
Q1 		$2.35M Buy
+1,473
New +$1.9M 0.01% 716
2016
Q2 		– Sell
-613
Closed -$127K – 830
2016
Q1 		$127K Sell
613
-554
-47% -$106K ﹤0.01% 692
2015
Q4 		$295K Sell
1,167
-8,000
-87% -$1.65M ﹤0.01% 642
2015
Q3 		$1.51M Buy
+9,167
New +$1.62M 0.01% 591

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Steven Cohen's NKTR Position: Q2 2026 in Review

Steven Cohen sold out of Nektar Therapeutics (NKTR) in Q2 2026, closing a stake of 13,364 shares — an estimated $962K sold.

Steven Cohen first reported a position in NKTR in Q3 2015 and held it in 13 quarters. The position peaked at $18.3M in Q4 2025. 239 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

  • Steven Cohen reported no remaining Nektar Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Steven Cohen sold 13,364 Nektar Therapeutics shares in Q2 2026, an estimated $962K.
  • Steven Cohen first reported a position in Nektar Therapeutics in Q3 2015 and held it in 13 quarters.
  • Steven Cohen's Nektar Therapeutics position peaked at $18.3M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.